Global Cell Therapy and Tissue Engineering Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 119

Report ID: 1914

Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules.
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules. Cell therapy, genetically modified cell therapy, gene therapy and tissue engineering are the four pillars of Regenerative Medicine (RM). These therapies have the potential to beneficially alter the quality of life and improve the health of patients with cell defects, genetic diseases, neurodegenerative diseases, tissue malignancies and other medical conditions.
In 2018, the global Cell Therapy and Tissue Engineering market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cell Therapy and Tissue Engineering status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell Therapy and Tissue Engineering development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Betalin Therapeutics
BioCardia, Inc
BioReliance Corporation
Biosolution Co., Ltd.
Brainstorm Cell Therapeutics, Inc
MaxCyte, Inc
Medigene AG
MEDIPOST CO., Ltd.
Mesoblast Limited
Miromatrix Medical, Inc.
MolMed S.p.A
Mustang Bio, Inc
NantKwest, Inc.
Neuralstem, Inc
NexImmune, Inc.
Nohla Therapeutics, Inc
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Rubius Therapeutics, Inc.
Sangamo Therapeutics, Inc
Voyager Therapeutics, Inc
Waisman Biomanufacturing
WindMIL Therapeutics, Inc.
Wuxi App Tec, Inc.
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT

Market segment by Type, the product can be split into
Cell Therapy
Tissue Engineering

Market segment by Application, split into
Cell Defects
Genetic Diseases
Neurodegenerative Diseases
Tissue Malignancies
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cell Therapy and Tissue Engineering status, future forecast, growth opportunity, key market and key players.
To present the Cell Therapy and Tissue Engineering development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cell Therapy and Tissue Engineering are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (2014-2025)
1.4.2 Cell Therapy
1.4.3 Tissue Engineering
1.5 Market by Application
1.5.1 Global Cell Therapy and Tissue Engineering Market Share by Application (2019-2025)
1.5.2 Cell Defects
1.5.3 Genetic Diseases
1.5.4 Neurodegenerative Diseases
1.5.5 Tissue Malignancies
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cell Therapy and Tissue Engineering Market Size
2.2 Cell Therapy and Tissue Engineering Growth Trends by Regions
2.2.1 Cell Therapy and Tissue Engineering Market Size by Regions (2019-2025)
2.2.2 Cell Therapy and Tissue Engineering Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Cell Therapy and Tissue Engineering Market Size by by Players
3.1.1 Global Cell Therapy and Tissue Engineering Revenue by by Players (2014-2019)
3.1.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by by Players (2014-2019)
3.1.3 Global Cell Therapy and Tissue Engineering Market Concentration Ratio (CR5 and HHI)
3.2 Cell Therapy and Tissue Engineering Key Players Head office and Area Served
3.3 Key Players Cell Therapy and Tissue Engineering Product/Solution/Service
3.4 Date of Enter into Cell Therapy and Tissue Engineering Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cell Therapy and Tissue Engineering Market Size by Type (2014-2019)
4.2 Global Cell Therapy and Tissue Engineering Market Size by Application (2014-2019)

5 North America
5.1 North America Cell Therapy and Tissue Engineering Market Size (2014-2019)
5.2 Cell Therapy and Tissue Engineering Key Players in North America
5.3 North America Cell Therapy and Tissue Engineering Market Size by Type
5.4 North America Cell Therapy and Tissue Engineering Market Size by Application

6 Europe
6.1 Europe Cell Therapy and Tissue Engineering Market Size (2014-2019)
6.2 Cell Therapy and Tissue Engineering Key Players in Europe
6.3 Europe Cell Therapy and Tissue Engineering Market Size by Type
6.4 Europe Cell Therapy and Tissue Engineering Market Size by Application

7 China
7.1 China Cell Therapy and Tissue Engineering Market Size (2014-2019)
7.2 Cell Therapy and Tissue Engineering Key Players in China
7.3 China Cell Therapy and Tissue Engineering Market Size by Type
7.4 China Cell Therapy and Tissue Engineering Market Size by Application

8 Japan
8.1 Japan Cell Therapy and Tissue Engineering Market Size (2014-2019)
8.2 Cell Therapy and Tissue Engineering Key Players in Japan
8.3 Japan Cell Therapy and Tissue Engineering Market Size by Type
8.4 Japan Cell Therapy and Tissue Engineering Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cell Therapy and Tissue Engineering Market Size (2014-2019)
9.2 Cell Therapy and Tissue Engineering Key Players in Southeast Asia
9.3 Southeast Asia Cell Therapy and Tissue Engineering Market Size by Type
9.4 Southeast Asia Cell Therapy and Tissue Engineering Market Size by Application

10 India
10.1 India Cell Therapy and Tissue Engineering Market Size (2014-2019)
10.2 Cell Therapy and Tissue Engineering Key Players in India
10.3 India Cell Therapy and Tissue Engineering Market Size by Type
10.4 India Cell Therapy and Tissue Engineering Market Size by Application

11 Central & South America
11.1 Central & South America Cell Therapy and Tissue Engineering Market Size (2014-2019)
11.2 Cell Therapy and Tissue Engineering Key Players in Central & South America
11.3 Central & South America Cell Therapy and Tissue Engineering Market Size by Type
11.4 Central & South America Cell Therapy and Tissue Engineering Market Size by Application

12 International Players Profiles
12.1 Betalin Therapeutics
12.1.1 Betalin Therapeutics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cell Therapy and Tissue Engineering Introduction
12.1.4 Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2014-2019))
12.1.5 Betalin Therapeutics Recent Development
12.2 BioCardia, Inc
12.2.1 BioCardia, Inc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cell Therapy and Tissue Engineering Introduction
12.2.4 BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
12.2.5 BioCardia, Inc Recent Development
12.3 BioReliance Corporation
12.3.1 BioReliance Corporation Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cell Therapy and Tissue Engineering Introduction
12.3.4 BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
12.3.5 BioReliance Corporation Recent Development
12.4 Biosolution Co., Ltd.
12.4.1 Biosolution Co., Ltd. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cell Therapy and Tissue Engineering Introduction
12.4.4 Biosolution Co., Ltd. Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
12.4.5 Biosolution Co., Ltd. Recent Development
12.5 Brainstorm Cell Therapeutics, Inc
12.5.1 Brainstorm Cell Therapeutics, Inc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cell Therapy and Tissue Engineering Introduction
12.5.4 Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
12.5.5 Brainstorm Cell Therapeutics, Inc Recent Development
12.6 MaxCyte, Inc
12.6.1 MaxCyte, Inc Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cell Therapy and Tissue Engineering Introduction
12.6.4 MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
12.6.5 MaxCyte, Inc Recent Development
12.7 Medigene AG
12.7.1 Medigene AG Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cell Therapy and Tissue Engineering Introduction
12.7.4 Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
12.7.5 Medigene AG Recent Development
12.8 MEDIPOST CO., Ltd.
12.8.1 MEDIPOST CO., Ltd. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cell Therapy and Tissue Engineering Introduction
12.8.4 MEDIPOST CO., Ltd. Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
12.8.5 MEDIPOST CO., Ltd. Recent Development
12.9 Mesoblast Limited
12.9.1 Mesoblast Limited Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cell Therapy and Tissue Engineering Introduction
12.9.4 Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
12.9.5 Mesoblast Limited Recent Development
12.10 Miromatrix Medical, Inc.
12.10.1 Miromatrix Medical, Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cell Therapy and Tissue Engineering Introduction
12.10.4 Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
12.10.5 Miromatrix Medical, Inc. Recent Development
12.11 MolMed S.p.A
12.12 Mustang Bio, Inc
12.13 NantKwest, Inc.
12.14 Neuralstem, Inc
12.15 NexImmune, Inc.
12.16 Nohla Therapeutics, Inc
12.17 ReNeuron Group plc
12.18 Richter-Helm BioLogics GmbH & Co. KG
12.19 RoosterBio, Inc
12.20 RoslinCT
12.21 Rubius Therapeutics, Inc.
12.22 Sangamo Therapeutics, Inc
12.23 Voyager Therapeutics, Inc
12.24 Waisman Biomanufacturing
12.25 WindMIL Therapeutics, Inc.
12.26 Wuxi App Tec, Inc.
12.27 ReNeuron Group plc
12.28 Richter-Helm BioLogics GmbH & Co. KG
12.28 RoosterBio, Inc
12.40 RoslinCT

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details